Literature DB >> 35190449

Antimicrobial resistance: a major priority for global focus.

Jonathan Cooke1.   

Abstract

Entities:  

Keywords:  clinical medicine; communicable diseases; continuing; economics; education; microbiological techniques; microbiology; pharmaceutical; pharmacy; virology

Mesh：

Substances：

Year:  2022        PMID： 35190449      PMCID： PMC8899676          DOI： 10.1136/ejhpharm-2022-003241

Source DB:  PubMed          Journal:  Eur J Hosp Pharm        ISSN： 2047-9956


× No keyword cloud information.
  5 in total

Review 1.  Potential burden of antibiotic resistance on surgery and cancer chemotherapy antibiotic prophylaxis in the USA: a literature review and modelling study.

Authors:  Aude Teillant; Sumanth Gandra; Devra Barter; Daniel J Morgan; Ramanan Laxminarayan
Journal:  Lancet Infect Dis       Date:  2015-10-22       Impact factor: 25.071

2.  Executive summary: a guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)(a).

Authors:  Ellen Jo Baron; J Michael Miller; Melvin P Weinstein; Sandra S Richter; Peter H Gilligan; Richard B Thomson; Paul Bourbeau; Karen C Carroll; Sue C Kehl; W Michael Dunne; Barbara Robinson-Dunn; Joseph D Schwartzman; Kimberle C Chapin; James W Snyder; Betty A Forbes; Robin Patel; Jon E Rosenblatt; Bobbi S Pritt
Journal:  Clin Infect Dis       Date:  2013-08       Impact factor: 9.079

3.  Impact of point-of-care C reactive protein in ambulatory care: a systematic review and meta-analysis.

Authors:  Jan Y Verbakel; Joseph J Lee; Clare Goyder; Pui San Tan; Thanusha Ananthakumar; Philip J Turner; Gail Hayward; Ann Van den Bruel
Journal:  BMJ Open       Date:  2019-02-01       Impact factor: 2.692

Review 4.  Respiratory tract infections (RTIs) in primary care: narrative review of C reactive protein (CRP) point-of-care testing (POCT) and antibacterial use in patients who present with symptoms of RTI.

Authors:  Jonathan Cooke; Carl Llor; Rogier Hopstaken; Matthew Dryden; Christopher Butler
Journal:  BMJ Open Respir Res       Date:  2020-09

5.  Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.

Authors: 
Journal:  Lancet       Date:  2022-01-19       Impact factor: 202.731
  5 in total
  1 in total

Review 1.  Les misérables: a Parallel Between Antimicrobial Resistance and COVID-19 in Underdeveloped and Developing Countries.

Authors:  Genesy Pérez Jorge; Isabella Carolina Rodrigues Dos Santos Goes; Marco Tulio Pardini Gontijo
Journal:  Curr Infect Dis Rep       Date:  2022-10-04       Impact factor: 3.663
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.